Skip to content

Drug interactions

Eliglustat + Tranylcypromine

Severity: Moderate

Eliglustat and Tranylcypromine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tranylcypromine has been listed as a CYP2D6 inhibitor in some references, which could raise eliglustat concentrations, but its inhibitory effect is weak and the evidence is limited. Raised eliglustat levels can prolong PR, QRS and QT intervals, but a contraindication is not well supported for this pair.

What this interaction means in plain words

Eliglustat and Tranylcypromine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eliglustat belongs to Miscellaneous; Tranylcypromine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible weak CYP2D6 inhibition by tranylcypromine reducing eliglustat metabolism.

What to do

Monitor ECG and for cardiac symptoms when starting the combination, and consider reducing eliglustat to once daily in extensive and intermediate metabolizers if exposure appears increased.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Tranylcypromine?

MediHelp rates the interaction as moderate. Eliglustat and Tranylcypromine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tranylcypromine has been listed as a CYP2D6 inhibitor in some references, which could raise eliglustat concentrations, but its inhibitory effect is weak and the evidence is limited. Raised eliglustat levels can prolong PR, QRS and QT intervals, but a contraindication is not well supported for this pair.

How serious is the interaction between Eliglustat and Tranylcypromine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and for cardiac symptoms when starting the combination, and consider reducing eliglustat to once daily in extensive and intermediate metabolizers if exposure appears increased.

What other medicines interact with Tranylcypromine?

MediHelp also lists interactions of Tranylcypromine with, for example, 5-HTP, Amitriptyline, Amoxapine. The full list is on the Tranylcypromine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in